** Shares of life science firm Avantor AVTR.N down 16.1% at $13 in early trading
** Stock trading at its lowest since April 2020
** Co announces Michael Stubblefield to step down as CEO as soon as successor is found
** Posts Q1 net sales of $1.58 bln, slightly below estimate of $1.60 bln - data compiled by LSEG
** AVTR reports adj. EPS of 23 cents, matching analysts' expectations
** Fourteen of 24 brokerages rate the stock "buy" or higher, 10 "hold"; median PT is $21.50 - data compiled by LSEG
** Including day's move, AVTR down 26.4% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。